
Sign up to save your podcasts
Or


Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.
GUESTS
Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics
Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs
Professor Colin Garner, Co Founder and Director, Antibiotic Research UK
By BBC Radio 44.7
3232 ratings
Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.
GUESTS
Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics
Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs
Professor Colin Garner, Co Founder and Director, Antibiotic Research UK

7,806 Listeners

374 Listeners

894 Listeners

1,067 Listeners

54 Listeners

41 Listeners

5,514 Listeners

1,799 Listeners

1,869 Listeners

1,068 Listeners

2,121 Listeners

1,980 Listeners

722 Listeners

57 Listeners

240 Listeners

68 Listeners

103 Listeners

681 Listeners

159 Listeners

3,205 Listeners

1,600 Listeners

3,444 Listeners

790 Listeners

195 Listeners

57 Listeners